Prognostic value of metastin expression in human pancreatic cancer

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Nagai, Kazuyuki ^a   Doi, Ryuichiro ^a   Katagiri, Fumihiko ^b   Ito, Tatsuo ^a   Kida, Atsushi ^a   Koizumi, Masayuki ^a   Masui, Toshihiko ^a   Kawaguchi, Yoshiya ^a   Tomita, Kenji ^a   Oishi, Shinya ^a   Fujii, Nobutaka ^a   Uemoto, Shinji ^a  

^a KYOTO UNIVERSITY   (Japan)

^b OITA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR 54; METASTIN; G PROTEIN COUPLED RECEPTOR; KISS1 PROTEIN, HUMAN; KISS1R PROTEIN, HUMAN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; HEALTH; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PANCREAS; PANCREAS TUMOR; PATHOLOGY; RECURRENT DISEASE; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEALTH; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; PROGNOSIS; RECEPTORS, G-PROTEIN-COUPLED; RECURRENCE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 60149108488     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-9     Document Type: Article

References (35)

1. Cancer statistics, 2002. A Jemal A Thomas T Murray M Thun, CA Cancer J Clin 2002 52 23 47 11814064
2. Cancer statistics, 2008. A Jemal R Siegel E Ward Y Hao J Xu T Murray MJ Thun, CA Cancer J Clin 2008 58 71 96 10.3322/CA.2007.0010 18287387
3. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. SF Sener A Fremgen HR Menck DP Winchester, J Am Coll Surg 1999 189 1 7 10.1016/S1072-7515(99)00075-7 10401733
4. Pancreatic cancer: basic and clinical aspects. G Schneider JT Siveke F Eckel RM Schmid, Gastroenterology 2005 128 1606 1625 10.1053/j.gastro.2005.04. 001 15887154
5. Genetics and biology of pancreatic ductal adenocarcinoma. AF Hezel AC Kimmelman BZ Stanger N Bardeesy RA Depinho, Genes Dev 2006 20 1218 1249 10.1101/gad.1415606 16702400
6. Metastasis suppressors genes in cancer. LJ Stafford KS Vaidya DR Welch, Int J Biochem Cell Biol 2008 40 874 891 10.1016/j.biocel.2007.12.016 18280770
7. KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. JH Lee ME Miele DJ Hicks KK Phillips JM Trent BE Weissman DR Welch, J Natl Cancer Inst 1996 88 1731 1737 10.1093/jnci/88.23.1731 8944003
8. Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. JH Lee DR Welch, Cancer Res 1997 57 2384 2387 9192814
9. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. M Kotani M Detheux A Vandenbogaerde D Communi JM Vanderwinden E Le Poul S Brezillon R Tyldesley N Suarez-Huerta F Vandeput C Blanpain SN Schiffmann G Vassart M Parmentier, J Biol Chem 2001 276 34631 34636 10.1074/jbc.M104847200 11457843
10. AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. AI Muir L Chamberlain NA Elshourbagy D Michalovich DJ Moore A Calamari PG Szekeres HM Sarau JK Chambers P Murdock K Steplewski U Shabon JE Miller SE Middleton JG Darker CG Larminie S Wilson DJ Bergsma P Emson R Faull KL Philpott DC Harrison, J Biol Chem 2001 276 28969 28975 10.1074/jbc.M102743200 11387329
11. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. T Ohtaki Y Shintani S Honda H Matsumoto A Hori K Kanehashi Y Terao S Kumano Y Takatsu Y Masuda Y Ishibashi T Watanabe M Asada T Yamada M Suenaga C Kitada S Usuki T Kurokawa H Onda O Nishimura M Fujino, Nature 2001 411 613 617 10.1038/35079135 11385580
12. Design and synthesis of downsized metastin (45-54) analogs with maintenance of high GPR54 agonistic activity. A Niida Z Wang K Tomita S Oishi H Tamamura A Otaka JM Navenot JR Broach SC Peiper N Fujii, Bioorg Med Chem Lett 2006 16 134 137 10.1016/j.bmcl.2005.09.054 16242330
13. Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. F Shirasaki M Takata N Hatta K Takehara, Cancer Res 2001 61 7422 7425 11606374
14. Metastin receptor is overexpressed in papillary thyroid cancer and activates MAP kinase in thyroid cancer cells. MD Ringel E Hardy VJ Bernet HB Burch F Schuppert KD Burman M Saji, J Clin Endocrinol Metab 2002 87 2399 10.1210/jc.87.5.2399 11994395
15. Quantitative reverse transcriptase polymerase chain reaction analysis for KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in hepatocellular carcinoma. M Ikeguchi Y Hirooka N Kaibara, J Cancer Res Clin Oncol 2003 129 531 535 10.1007/s00432-003-0469-z 12898236
16. Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome. M Sanchez-Carbayo P Capodieci C Cordon-Cardo, Am J Pathol 2003 162 609 617 12547718
17. Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma. DK Dhar H Naora H Kubota R Maruyama H Yoshimura Y Tonomoto M Tachibana T Ono H Otani N Nagasue, Int J Cancer 2004 111 868 872 10.1002/ijc.20357 15300798
18. Clinical significance of the loss of KiSS-1 and orphan G-protein-coupled receptor (hOT7T175) gene expression in esophageal squamous cell carcinoma. M Ikeguchi K Yamaguchi N Kaibara, Clin Cancer Res 2004 10 1379 1383 10.1158/1078-0432.CCR-1519-02 14977840
19. KiSS-1 expression in human breast cancer. TA Martin G Watkins WG Jiang, Clin Exp Metastasis 2005 22 503 511 10.1007/s10585-005-4180-0 16320113
20. Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer. K Hata DK Dhar Y Watanabe H Nakai H Hoshiai, Eur J Cancer 2007 43 1452 1459 10.1016/j.ejca.2007.03.004 17442564
21. KiSS-1 overexpression as an independent prognostic marker in hepatocellular carcinoma: an immunohistochemical study. K Schmid X Wang A Haitel W Sieghart M Peck-Radosavljevic M Bodingbauer S Rasoul-Rockenschaub F Wrba, Virchows Arch 2007 450 143 149 10.1007/s00428-006-0352-9 17216189
22. The neuroendocrine physiology of kisspeptin in the human. WS Dhillo KG Murphy SR Bloom, Rev Endocr Metab Disord 2007 8 41 46 10.1007/s11154-007-9029-1 17323132
23. Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system. EJ Mead JJ Maguire RE Kuc AP Davenport, Br J Pharmacol 2007 151 1143 1153 17519946 10.1038/sj.bjp.0707295
24. Metastin and its variant forms suppress migration of pancreatic cancer cells. T Masui R Doi T Mori E Toyoda M Koizumi K Kami D Ito SC Peiper JR Broach S Oishi A Niida N Fujii M Imamura, Biochem Biophys Res Commun 2004 315 85 92 10.1016/j.bbrc.2004.01.021 15013429
25. Establishment and clinical application of enzyme immunoassays for determination of luteinizing hormone releasing hormone and metastin. F Katagiri K Tomita S Oishi M Takeyama N Fujii, J Pept Sci 2007 13 422 429 10.1002/psc.863 17486693
26. International Union Against Cancer (UICC): TNM Classification of Malignant Tumours New York: Wiley-Liss 6 2002
27. Preparation and characterization of hetero-bifunctional cross-linking reagents for protein modifications. T Kitagawa T Shimozono T Aikawa T Yoshida H Nishimura, Chem Pharm Bull 1981 29 1130 1135
28. KISS1 metastasis suppression and emergent pathways. JF Harms DR Welch ME Miele, Clin Exp Metastasis 2003 20 11 18 10.1023/A:1022530100931 12650602
29. Identification and characterization of mouse metastasis-suppressor KiSS1 and its G-protein-coupled receptor. LJ Stafford C Xia W Ma Y Cai M Liu, Cancer Res 2002 62 5399 5404 12359743
30. KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha -induced block of p65/p50 nuclear translocation. C Yan H Wang DD Boyd, J Biol Chem 2001 276 1164 1172 10.1074/jbc.M008681200 11060311
31. Kisspeptin-10, a KiSS-1/metastin-derived decapeptide, is a physiological invasion inhibitor of primary human trophoblasts. M Bilban N Ghaffari-Tabrizi E Hintermann S Bauer S Molzer C Zoratti R Malli A Sharabi U Hiden W Graier M Knofler F Andreae O Wagner V Quaranta G Desoye, J Cell Sci 2004 117 1319 1328 10.1242/jcs.00971 15020672
32. Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma. T Koshiba R Hosotani M Wada Y Miyamoto K Fujimoto JU Lee R Doi S Arii M Imamura, Cancer 1998 82 642 650 10.1002/(SICI)1097-0142(19980215)82:4<642::AID-CNCR5>3.0.CO;2-N 9477095
33. Chromosome localization and genomic structure of the KiSS-1 metastasis suppressor gene (KISS1). A West PJ Vojta DR Welch BE Weissman, Genomics 1998 54 145 148 10.1006/geno.1998.5566 9806840
34. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma. T Yatsuoka M Sunamura T Furukawa S Fukushige T Yokoyama H Inoue K Shibuya K Takeda S Matsuno A Horii, Am J Gastroenterol 2000 95 2080 2085 10.1111/j.1572-0241.2000.02171.x 10950061
35. Detection of genetic alterations in pancreatic cancers by comparative genomic hybridization coupled with tissue microdissection and degenerate oligonucleotide primed polymerase chain reaction. T Harada K Okita K Shiraishi N Kusano T Furuya A Oga S Kawauchi S Kondoh K Sasaki, Oncology 2002 62 251 258 10.1159/000059573 12065873